Keywords: Canada, Drug safety and efficacy, R&D, Post-marketing surveillance, Health Canada

Limitations of drug safety and efficacy in Canada revealed in new Health Council report

Article | 19 November 2010

A commissioned discussion paper released this week by the Health Council of Canada, titled Keeping an Eye on Prescription Drugs, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in